Dr. Stella Immanuel was thrust into the spotlight when she became the center of attention in a viral video featuring doctors discussing hydroxychloroquine.
Immanuel’s impassioned support of hydroxychloroquine as a treatment for the coronavirus drew quite a bit of attention, particularly negative coverage from mainstream media sites.
“Stella Immanuel – the doctor behind the unproven coronavirus cure claim,” the BBC said.
“4 Things to Know About Dr. Stella Immanuel, Trump’s New Favorite COVID Doc,” Men’s Health reported.
Likely due in no small part to that video and the subsequent negative coverage, Immanuel tweeted on Aug. 18 that the Washington, D.C., Texas and Louisiana medical boards had “opened queries” on her.
Since DC, Texas and Louisiana medical boards and Houston health dept have all opened queries on me. I’ve hired good attorneys so I don’t get shut down. People are asking how they can help. Donate here & share the link. Thank you and God bless.https://t.co/LFukea4vwV
— Stella Immanuel MD (@stella_immanuel) August 18, 2020
Well, at least one of those boards has dismissed a complaint against the doctor.
Immanuel tweeted out Wednesday that the Texas Medical Board had dismissed the complaint due to “insufficient evidence.”
Texas medical board dismisses the complaint against me. The haters have been defeated and God has showed Himself as my protector and defender. God bless TMB, God bless Texas, God bless America. Good will win. American will win. pic.twitter.com/FJxKNPToeS
— Stella Immanuel MD (@stella_immanuel) September 2, 2020
“The investigation referenced above has been dismissed because the Board determined there was insufficient evidence to prove that a violation of the Medical Practices Act occurred,” read the letter to Immanuel from the board, dated Aug. 26.
“As such, this complaint has been dismissed without prejudice,” the letter continued. “No further action will be taken concerning this complaint.”
Dr. Immanuel has not yet revealed the status of the other queries involving D.C. and Louisiana boards.